Which stimulant would you recommend for an adult with attention‑deficit/hyperactivity disorder and no cardiovascular disease or other contraindications?

Recommended Stimulant for Adult ADHD

Start with methylphenidate (MPH) or lisdexamfetamine (LDX) as first-line treatment for adults with ADHD and no contraindications. 1, 2

First-Line Choice: Methylphenidate vs. Lisdexamfetamine

Both medications are guideline-recommended first-line agents, but the choice depends on specific patient factors:

Methylphenidate (MPH)

• Start with 5 mg twice daily (morning and noon), titrating upward by 5-10 mg increments weekly 1
• Maximum daily dose typically 60-65 mg/day for adults 1
• Choose extended-release formulations (12-hour duration) to improve adherence and avoid in-school/work dosing 1, 2
• Approximately 70% response rate when used as monotherapy 1

Lisdexamfetamine (LDX)

• Highest effect size among stimulants in meta-analysis (SMD -0.89) 3
• Prodrug with 12-hour duration and minimal abuse potential compared to immediate-release amphetamines 2
• Particularly advantageous if substance abuse history is a concern (though not active abuse/dependence) 2

Practical Titration Algorithm

Week 1: MPH 5 mg twice daily OR LDX starting dose

• Obtain ADHD rating scales from patient and significant other
• Monitor blood pressure, pulse, weight 1

Week 2: Increase to MPH 10 mg twice daily if inadequate response

• Contact via visit or phone
• Assess side effects and symptom improvement 1

Week 3-4: Continue titration in 5-10 mg increments weekly

• Stop when symptoms resolve and impairment diminishes
• Select dose with most benefit and fewest side effects 1

Maximum doses:

• MPH: 1.0 mg/kg or 65 mg/day 1
• Mixed amphetamine salts: 0.9 mg/kg or 40 mg/day 1

If First Stimulant Fails

Switch to alternative stimulant class - approximately 90% of patients respond when both MPH and amphetamines are tried 1. If patient fails MPH, trial dexamfetamine/lisdexamfetamine, or vice versa.

Critical Monitoring Points

Absolute Contraindications (Do Not Prescribe):

• Active psychosis or schizophrenia 1
• Concurrent MAO inhibitor use 1
• Glaucoma 1
• Active stimulant abuse/dependence 1

Relative Considerations (Not Contraindications):

• Anxiety disorders: Stimulants are safe and effective 1
• History of tics: MPH does not worsen tics in controlled studies 1
• Controlled seizure disorder: Safe once stabilized on anticonvulsants 1
• Past substance abuse (non-stimulant): Not a contraindication, but requires closer monitoring 1

Common Pitfalls to Avoid

1. Underdosing: Adults often need higher total daily doses than children due to longer waking hours requiring coverage 1

2. Stopping too early: If first stimulant fails, try the alternative class before abandoning stimulant therapy entirely 1

3. Missing comorbid conditions: Screen for substance abuse, bipolar disorder, and obtain collateral information from significant others, as adults with ADHD often underestimate their symptoms 1

4. Inadequate monitoring: Check blood pressure, pulse, weight, and psychiatric symptoms (mood, anxiety, psychosis) at each dose adjustment 1

The evidence strongly supports methylphenidate or lisdexamfetamine as equally appropriate first-line choices 1, 2, with lisdexamfetamine showing slightly higher effect sizes in recent meta-analyses 3. The 2024 Asian guidelines and 2025 UK guidance both endorse this approach 4, 2.